Can extra support keep people with opioid addiction in treatment longer?
NCT ID NCT06837662
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding addiction counseling and a community peer helper to regular primary care helps people with opioid use disorder stay on their medication (buprenorphine) and keep coming to their doctor visits. About 70 adults with opioid dependence and other medical conditions will either get standard care or standard care plus the extra support. Researchers will track how long participants stay on medication and how often they see their care team over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Eligibility/Inclusion Criteria. For Aim 3, criteria we seek to recruit include: * Patient participants 18 years and older * Have an OUD-related diagnosis (e.g. Opioid Use Disorder in remission, Opioid Dependence, Opioid Abuse, Substance Use Disorder - opioids, etc.), or have used fentanyl or heroin over the past 30 days * Who meet at least one of the following criteria: * Present to primary care at Central City Concern (CCC) within 8 weeks of starting or re-starting a treatment episode (defined as starting MOUD after not having received prescribed MOUD in an outpatient setting for OUD in the prior 30 days). * Who present to primary care at CCC and are not seeking treatment with MOUD and have not engaged in counseling services (e.g. harm reduction counseling) in the prior 30 days * Have been receiving MOUD in prior 30 days but had a return to use (used fentanyl or heroin) within the past 30 days * Medical complexity (e.g. self-reported or verified in patient's electronic health record) * Have access to phone and/or computer for follow-up activities * Desire to engage in counseling and/or peer services Exclusion Criteria: * Patient participants who present for addiction treatment but are ineligible to receive on-going services at Central City (i.e. they have existing primary care at another location, or are currently receiving opioid use disorder treatment at another clinic, such as methadone clinic) may not participate in the study. * Patient participants who are not able to verbally consent may not participate in the study. * Patients who do not have addiction to opioids may not participate in the study. * Patients who participated in Aim 2 would not be eligible for Aim 3 * Patients who lack stable phone access may not participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Complex medical patients are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Central City Concern
RECRUITINGPortland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearables and a secure platform: can digital health reach remote patients and space?
- Can exercise boost brain and body health during opioid treatment?
- Can four group sessions teach safer habits to injection drug users?
- Could a simple helpline help fight opioid addiction?
- Zapping the brain to beat opioid relapse: new study tests Non-Invasive technique
- New parenting program aims to strengthen bonds for moms battling opioid addiction